A carregar...
IMMU-01. TEMOZOLOMIDE-RESISTANT CAR-T ENHANCES GLIOBLASTOMA CLEARANCE BY CONCURRENT CHEMOTHERAPY AND IMMUNOTHERAPY
Despite refinements in multimodal management of glioblastoma (GBM) patients, long-term problem-free survival is still dismal. Post resection GBM patients who are concurrently treated with radiation and chemotherapy had a modest median survival of 14. 6 months. Immunotherapy for GBM has often been co...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692404/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.460 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|